Cullinan Oncology and MAB Discovery Collaborate on Novel Antibody Therapeutics

20.02.2018 - US Cullinan Oncology, based in Cambridge, MA, and German MAB Discovery (MABD) announced the initiation of a collaboration to develop novel antibody therapeutics based on MABD's...